ANG Lifesciences India informs about updates

02 Nov 2021 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, ANG Lifesciences India has informed that the Company has received the In-principal Approval vide letter no. LO/Migration/SC/IP/258/2021-22 dated 01-Nov.-2021 for Migration of equity shares of the company from BSE SME Platform to Main Board of BSE. The company enclosed the copy of In principal Approval of the BSE.

The above information is a part of company’s filings submitted to BSE.

ANG Lifesciences Share Price

24.82 0.68 (2.82%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×